PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Microbiology, University of Washington, Seattle, WA 98109, USA.\', \'HDT Bio, Seattle, WA 98102, USA.\', \'PAI Life Sciences, Seattle, WA 98102, USA.\', \'Washington National Primate Research Center, Seattle, WA 98121, USA.\', \'Department of Biochemistry, University of Washington, Seattle, WA 98195, USA.\', \'Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA 98109, USA.\', \'Department of Immunology, University of Washington, Seattle, WA 98109, USA.\', \'Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.\', \'Department of Microbiology, University of Washington, Seattle, WA 98109, USA. fullerdh@uw.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • eabc939610.1126/scitranslmed.abc9396
?:hasPublicationType
?:journal
  • Science translational medicine
is ?:pmid of
?:pmid
?:pmid
  • 32690628
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 9.7
?:rankingScore_hIndex
  • 147
is ?:relation_isRelatedTo_publication of
?:title
  • An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all